Key result
In middle-aged to elderly men with andropausal symptoms, serum testosterone was inversely associated with brachial artery flow-mediated dilatation (β = -0.17, p = 0.0226).
Why the study?
Is endogenous serum testosterone associated with brachial artery flow-mediated dilatation in middle-aged men with andropausal symptoms?
Cross-Sectional (n=83)
Is endogenous serum testosterone associated with brachial artery flow-mediated dilatation in middle-aged men with andropausal symptoms?
Effect estimate: β = -0.17
p-value: p=0.0226
Endogenous serum testosterone is inversely correlated with brachial artery flow-mediated dilatation in middle-aged men with andropausal symptoms, suggesting a potential adverse effect on endothelial function.
In aging men, serum endogenous testosterone is inversely associated with common carotid intima-media thickness (IMT) and directly with beneficial plasma lipid levels; however, the relationship to endothelial function is poorly characterized. We examined the association between serum testosterone and endothelium-dependent brachial artery flow-mediated dilatation (FMD) in middle-aged to elderly men. A group of 83 men aged 40?69 years (mean 55.9 ± 7.5 [SD]) with andropausal symptoms were studied. We measured their serum lipids, testosterone, luteinizing hormone, mean carotid IMT and brachial artery FMD by high resolution B-mode ultrasound. Brachial FMD correlated inversely with vessel diameter (r = -0.38, p = 0.0004), alcohol consumption (r = -0.22, p = 0.047) and serum testosterone (r = -0.27, p = 0.01), but not with luteinizing hormone. In multivariate analysis, FMD was explained by testosterone (β = -0.17, p = 0.0226), high density lipoprotein cholesterol (β = 4.17, p = 0.0312) and vessel diameter (β = -4.37, p < 0.0001) when adjusted for age, body mass index, triglycerides, blood pressure, carotid IMT, smoking, alcohol consumption, cardiovascular diseases and use of lipid lowering medication (HMG-CoA reductase inhibitors). In middle-aged to elderly men, there is an inverse correlation between serum testosterone and brachial FMD. These data suggest that testosterone may have an adverse effect on systemic endothelial function.
No takes yet. Share an insight, caveat, or question.
Mäkinen et al. (2011) conducted a cross-sectional in Andropausal symptoms (late-onset hypogonadism) (n=83). Serum testosterone was evaluated on Endothelium-dependent brachial artery flow-mediated dilatation (FMD) (β = -0.17, p=0.0226). In middle-aged to elderly men with andropausal symptoms, serum testosterone was inversely associated with brachial artery flow-mediated dilatation (β = -0.17, p = 0.0226).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: